Communications Medicine (Dec 2022)
Intraglandular mesenchymal stem cell treatment induces changes in the salivary proteome of irradiated patients
Abstract
Lynggaard et al. profile the salivary proteome and metaproteome in patients with head and neck cancer who have received radiation therapy and an intraglandular mesenchymal stem cell (MSC) treatment for radiation-induced xerostomia and in healthy controls. MSC therapy impacts the composition of the salivary proteome in the longer-term.